Date published: 2026-4-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

A230050P20Rik Activators

A230050P20Rik activators comprise a suite of chemical compounds that enhance the protein's functional activity through various distinct but interconnected signaling pathways. Compounds such as Forskolin, Dibutyryl-cAMP, and Isoproterenol exert their effects by increasing intracellular levels of cAMP, which activates PKA. This kinasehas a broad range of substrates, potentially including those that interact with A230050P20Rik, leading to its functional activation. Ionomycin and A23187 (Calcimycin) raise intracellular calcium levels, which could activate calcium-dependent kinases that phosphorylate and enhance A230050P20Rik's activity. On a different note, PMA activates PKC, which may phosphorylate substrates within A230050P20Rik's pathways, thereby amplifying its functional role. Similarly, SNAP, by elevating cGMP levels, indirectly promotes the activation of cGMP-dependent protein kinases which could, in turn, activate A230050P20Rik if it is regulated by cGMP-mediated signaling. EGCG, although primarily known as a kinase inhibitor, could paradoxically enhance the activity of A230050P20Rik through the inhibition of competitive or negative regulatory kinases, thereby allowing a compensatory upregulation of A230050P20Rik's function.

Inhibition of specific signaling pathways often results in the activation of alternative routes that can lead to enhanced activity of proteins like A230050P20Rik. LY294002, U0126, and SB203580, which are inhibitors of PI3K, MEK1/2, and p38 MAP kinase respectively, may induce such compensatory effects. By inhibiting key regulators of signaling pathways, these compounds may shift cellular dynamics in a way that favors the activation of A230050P20Rik, either through direct effects on signaling components or through an intricate web of feedback and feedforward loops. Zaprinast, by inhibiting phosphodiesterases, increases cGMP levels and activates cGMP-dependent kinases, potentially leading to the activation of A230050P20Rik. Collectively, these A230050P20Rik activators function through a diverse array of mechanisms but converge on the common outcome of enhancing the activity of A230050P20Rik without the need for increased gene expression, ensuring that the protein's functional capacity is maximized in the context of cellular signaling.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium concentration. Elevated calcium levels can activate calcium-dependent protein kinases, which may then phosphorylate and increase the activity of A230050P20Rik if it is regulated by calcium-mediated signaling.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a potent activator of protein kinase C (PKC), which is involved in a variety of cellular functions. Activation of PKC has the potential to phosphorylate and enhance the activity of proteins in the same signaling pathways as A230050P20Rik.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. By mimicking cAMP, it can potentially enhance the activity of A230050P20Rik through PKA-mediated signaling pathways.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is known to inhibit certain types of protein kinases. Inhibition of competitive kinase signaling pathways could lead to the relative upregulation and functional enhancement of A230050P20Rik if it is part of a compensatory cellular response.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a specific inhibitor of PI3K. By inhibiting PI3K/Akt signaling, it may lead to the activation of compensatory pathways that enhance the function of A230050P20Rik.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK1/2, which are kinases involved in the MAPK/ERK pathway. Inhibition of this pathway can lead to the activation of alternative pathways that could enhance the functional activity of A230050P20Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a specific inhibitor of p38 MAP kinase. By selectively inhibiting the p38 MAPK pathway, it could activate alternative signaling pathways, potentially enhancing the activity of A230050P20Rik.